plerixafor

Generic: plerixafor

Labeler: camber pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name plerixafor
Generic Name plerixafor
Labeler camber pharmaceuticals, inc.
Dosage Form INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients

plerixafor 24 mg/1.2mL

Manufacturer
Camber Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 31722-373
Product ID 31722-373_447a1ba3-4d5e-f506-e063-6394a90aab72
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA217560
Listing Expiration 2026-12-31
Marketing Start 2025-06-16

Pharmacologic Class

Established (EPC)
hematopoietic stem cell mobilizer [epc]
Physiologic Effect
increased hematopoietic stem cell mobilization [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 31722373
Hyphenated Format 31722-373

Supplemental Identifiers

RxCUI
828700
UPC
0331722373319
UNII
S915P5499N
NUI
N0000178326 N0000178324

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name plerixafor (source: ndc)
Generic Name plerixafor (source: ndc)
Application Number ANDA217560 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 24 mg/1.2mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-USE in 1 CARTON (31722-373-31) / 1.2 mL in 1 VIAL, SINGLE-USE
source: ndc

Packages (1)

Ingredients (1)

plerixafor (24 mg/1.2mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "447a1ba3-4d5e-f506-e063-6394a90aab72", "openfda": {"nui": ["N0000178326", "N0000178324"], "upc": ["0331722373319"], "unii": ["S915P5499N"], "rxcui": ["828700"], "spl_set_id": ["bb8e1167-8378-4e73-9bcb-d69093ec829b"], "pharm_class_pe": ["Increased Hematopoietic Stem Cell Mobilization [PE]"], "pharm_class_epc": ["Hematopoietic Stem Cell Mobilizer [EPC]"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-USE in 1 CARTON (31722-373-31)  / 1.2 mL in 1 VIAL, SINGLE-USE", "package_ndc": "31722-373-31", "marketing_start_date": "20250616"}], "brand_name": "Plerixafor", "product_id": "31722-373_447a1ba3-4d5e-f506-e063-6394a90aab72", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Hematopoietic Stem Cell Mobilizer [EPC]", "Increased Hematopoietic Stem Cell Mobilization [PE]"], "product_ndc": "31722-373", "generic_name": "Plerixafor", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Plerixafor", "active_ingredients": [{"name": "PLERIXAFOR", "strength": "24 mg/1.2mL"}], "application_number": "ANDA217560", "marketing_category": "ANDA", "marketing_start_date": "20250616", "listing_expiration_date": "20261231"}